NCT07236333Completed
The Role of CALLY and HAALP in Ulcerative Colitis
The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
The aim of this study is to demonstrate the type and amount of retention in the colon during ulcerative colitis activation, as well as the relationship between C-reactive protein (CRP), albumin and the calculated CALLY index. The investigators also aim to establish whether this ratio can be used to indicate activation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 24 Sept 2025
- Start date
- 1 Jun 2020
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Ataturk University
- Diseases
- Ulcerative colitis
- NCT number
- NCT07236333
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Jun 2020 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- no UC
Who the study is looking for
- under 18
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Akdeniz University Coordinator of this site? Confirm its status | Antalya | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.